XML 146 R137.htm IDEA: XBRL DOCUMENT v3.25.3
Net financial results (Details) - BRL (R$)
R$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Financial expenses [Abstract]        
Interest on loans, financing and debentures (1)     R$ (4,194,406) R$ (3,059,902)
Premium expenses on early settlements     89,026
Amortization of transaction costs     (75,916) (57,716)
Interest expenses on lease liabilities (2)     (347,320) (335,223)
Other     (363,271) (397,459)
Financial expenses     (5,069,939) (3,850,300)
Financial income [Abstract]        
Cash and cash equivalents and marketable securities     1,144,245 1,212,405
Other     139,962 89,638
Financial income     1,284,207 1,302,043
Results from derivative financial instruments [Abstract]        
Income     9,008,280 2,401,971
Expenses     (1,576,658) (6,144,397)
Derivative financial instruments, net R$ 1,079,117 R$ 782,452 7,431,622 (3,742,426)
Monetary and exchange rate variations, net [Abstract]        
Exchange rate variations on loans, financing and debentures     10,914,087 (8,012,235)
Leases     381,893 (280,673)
Other assets and liabilities (3)     (1,768,911) 1,337,630
Monetary and exchange variations, net R$ 1,333,984 R$ 1,231,379 9,527,069 (6,955,278)
Net financial result     13,172,959 (13,245,961)
Interest costs capitalised     205,409 833,401
Reclassification to biological assets     R$ 200,177 R$ 184,776